CDC strengthens recommendation on Covid-19 vaccine booster doses for adults

The US Centers for Disease Control and Prevention (CDC) is strengthening its recommendation on COVID-19 vaccine booster doses for adults, CDC Director Rochelle Walensky said.

Coronavirus vaccine, Covid-19 vaccines
ANI US
2 min read Last Updated : Nov 30 2021 | 10:56 AM IST

The US Centers for Disease Control and Prevention (CDC) is strengthening its recommendation on COVID-19 vaccine booster doses for adults, CDC Director Rochelle Walensky said.

"Today, CDC is strengthening its recommendation on booster doses for individuals who are 18 years and older," Walensky said in a statement on Monday. "Everyone aged 18 and older should get a booster shot either... six months after their initial Pfizer or Moderna series or two months after their initial J & J vaccine."

Walensky said the recent surge of the novel coronavirus Omicron variant has highlighted the importance of immunization along with other protective measures.

Early data from South Africa suggest increased transmission of the Omicron variant and scientists in the United States and around the world are examining vaccine effectiveness related to this variant, she said.

The CDC director encouraged people to get vaccinated and take a test if they feel sick.

On Friday, the World Health Organization identified the new strain of the coronavirus first reported in South Africa, as one of concern, since it may be more transmissible and dangerous. However, local doctors and officials have reported that the reported cases are mild. Cases have been confirmed in multiple countries and some governments rushed to suspend travel with southern African nations slow the spread of the new variant.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusUnited StatesCoronavirus Vaccine

First Published: Nov 30 2021 | 10:55 AM IST

Next Story